Cargando…
The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background and objectives: Spinal muscular atrophy (SMA) is a neurodegenerative disease that leads to progressive proximal muscle weakness and muscle atrophy. To assess the beneficial and adverse effects of nusinersen, a promising intervention for SMA, we conducted a systematic search and meta-analy...
Autores principales: | Abbas, Kirellos Said, Eltaras, Mennatullah Mohamed, El-Shahat, Nahla Ahmed, Abdelazeem, Basel, Shaqfeh, Mahmoud, Brašić, James Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874456/ https://www.ncbi.nlm.nih.gov/pubmed/35208537 http://dx.doi.org/10.3390/medicina58020213 |
Ejemplares similares
-
Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”
por: Abdelazeem, Basel, et al.
Publicado: (2022) -
Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
por: Abdelazeem, Basel, et al.
Publicado: (2022) -
Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018) -
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study
por: Acsadi, Gyula, et al.
Publicado: (2021) -
Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qiao, Yue, et al.
Publicado: (2023)